Post-Grant Review Of Antibody-Drug Conjugate Patent Requested

Mealey's (January 28, 2021, 9:27 AM EST) -- ALEXANDRIA, Va. — Two pharmaceutical companies on Jan. 22 petitioned the Patent Trial and Appeal Board for post-grant review (PGR) of a recently issued patent relating to cancer therapy.

(Daiichi Sankyo...
To view the full article, register now.